Strikingly, increased expression of PD-1, ICOS and IL-21 by TFH cells were associated with disease burden, and CLL TFH cells were also found to over-express other stimulatory molecules such as IFNγ, TIGIT and CD40L. This evidence concerns the gene ICOS and B-cell chronic lymphocytic leukemia.